Journal of Addiction Medicine

Papers
(The H4-Index of Journal of Addiction Medicine is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine101
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases71
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language68
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations56
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report55
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report42
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations41
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.41
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease40
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes38
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial36
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study34
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions32
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review30
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–201929
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program27
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study25
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder25
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals25
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds24
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder23
Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge22
0.20026683807373